Company profile
Quanterix Corporation
NASDAQ: QTRX · Healthcare · Medical - Devices
PublicHQ Billerica, MACIK 0001503274Reports USD
#318 of 1,420 Healthcare companies by revenue44th-percentile growth
EA Score
56CFH 53DQ 58GM 56SS 63
v0.1 · 65/100 weight · provisional
↑ workforce scale, balance-sheet leverage · ↓ Piotroski F, listing tenure
Methodology →Revenue TTM
$144.9M
Rev growth YoY (TTM)
+8.2%
Net income (FY)
-$107.2M
Employees
450
as of 2026-08-13
Market cap
$138.0M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$138.9M$138.9M2025
Net income-$107.2M-$107.2M2025
Operating income-$125.5M-$125.5M2025
Total assets$418.8M$418.8M2025
Liabilities$123.0M$123.0M2025
Equity$295.7M$295.7M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY22
FY23
FY23
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product67%
Service And Other Revenue32%
License and Service1%
Grant0%
By geography
North America53%
EMEA31%
Asia Pacific16%
The read
What is Quanterix Corporation’s revenue?
Quanterix Corporation booked $138.9M in FY2025 revenue, growing 1.1% year over year — about the middle of the pack among Healthcare companies we track, at a -77.1% net margin.
Peers · Healthcare
InfuSystem Holdings, Inc.80B+Beam Therapeutics Inc.62CSpok Holdings, Inc.83B+Telesis Bio, Inc.——National Research Corporation75B+RxSight, Inc.59CKey facts
CEOEverett V. Cunningham
SectorHealthcare
IndustryMedical - Devices
HeadquartersBillerica, MA
ExchangeNASDAQ: QTRX
Employees450
IPO date2017-12-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.